ArticleJournal for immunotherapy of cancer2023

Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB-IV NSCLC (LCDigital-IO Study): a multicenter retrospective study.

Shaowei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.